<DOC>
	<DOCNO>NCT00044525</DOCNO>
	<brief_summary>Breast cancer common form cancer among woman develop country , account approximately one-fifth female cancer United States . Although mortality rate decline country , remain leading cause death woman age 40-55 year . The median survival woman metastatic breast cancer 2-3 year significant variability population . The primary goal treatment patient metastatic breast cancer improvement maintenance quality life prolongation survival . The taxanes , paclitaxel docetaxel , incorporate treatment metastatic breast cancer 1990 's . The usefulness taxanes limit development tumor resistance agent . This phase II trial BAY59-8862 conduct determine anti-tumor efficacy BAY59-8862 taxane-resistant metastatic breast cancer .</brief_summary>
	<brief_title>Evaluation BAY59-8862 Taxane-Resistant Metastatic Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Taxane</mesh_term>
	<criteria>Female patient proven diagnosis metastatic breast cancer Measurable disease define presence least one measurable lesion Patients must receive least 3 week continuous therapy Taxane patient must subsequently develop progressive disease either treatment within 6 month treatment Patients fail hormone therapy Life expectancy least 12 week . Adequate bone marrow , liver kidney function Patients active brain metastasis may include Excluded medical condition like : preexisting neuropathy , active heart diseases ischemia ; surgery within 4 week study entry ; serious infection ; HIV infection ; chronic hepatitis B C ; patient brain metastasis must without seizure ; hypersensitivity taxanes ; organ transplant ; previous cancer Excluded therapy medication , previous concomitant : anticancer chemotherapy immunotherapy study within 4 week prior study entry ; two prior anticancer chemotherapy regimens ; radiotherapy study within 4 week prior study entry ; bone marrow transplant Others : pregnant breastfeeding patient ; woman enrol trial must use adequate barrier birth control measure course trial ; substance abuse , medical , psychological social condition may interfere patient 's participation .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Taxane</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Metastasis</keyword>
</DOC>